New Analyst Forecast: $RCKT Given 'Hold' Rating

We just received data on a new analyst forecast for $RCKT. Needham gave a rating of 'Hold' for $RCKT.

$RCKT Analyst Ratings

Wall Street analysts have issued reports on $RCKT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 06/17/2025
• Canaccord Genuity issued a "Buy" rating on 06/03/2025
• B of A Securities issued a "Buy" rating on 05/28/2025
• BMO Capital issued a "Outperform" rating on 05/28/2025
• Scotiabank issued a "Sector Outperform" rating on 05/28/2025
• Chardan Capital issued a "Buy" rating on 05/28/2025
• Cantor Fitzgerald issued a "Overweight" rating on 05/16/2025

To track analyst ratings and price targets for $RCKT, check out Quiver Quantitative's $RCKT forecast page.

$RCKT Price Targets

Multiple analysts have issued price targets for $RCKT recently. We have seen 13 analysts offer price targets for $RCKT in the last 6 months, with a median target of $13.0.

Here are some recent targets:

• Colin Bristow from UBS set a target price of $5.0 on 06/17/2025
• Whitney Ijem from Canaccord Genuity set a target price of $11.0 on 06/03/2025
• Jason Zemansky from B of A Securities set a target price of $9.0 on 05/28/2025
• Kostas Biliouris from BMO Capital set a target price of $8.0 on 05/28/2025
• Greg Harrison from Scotiabank set a target price of $19.0 on 05/28/2025
• Mani Foroohar from Leerink Partners set a target price of $8.0 on 05/28/2025
• Geulah Livshits from Chardan Capital set a target price of $17.0 on 05/28/2025

$RCKT Insider Trading Activity

$RCKT insiders have traded $RCKT stock on the open market 18 times in the past 6 months. Of those trades, 2 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $RCKT stock by insiders over the last 6 months:

• KINNARI PATEL (See Remarks) has made 1 purchase buying 21,099 shares for an estimated $99,165 and 3 sales selling 8,254 shares for an estimated $78,447.
• GAURAV SHAH (CEO) has made 1 purchase buying 20,000 shares for an estimated $101,600 and 2 sales selling 5,874 shares for an estimated $38,160.
• JONATHAN DAVID SCHWARTZ (See Remarks) has made 0 purchases and 3 sales selling 8,915 shares for an estimated $84,599.
• AARON ONDREY (Chief Financial Officer) has made 0 purchases and 2 sales selling 8,966 shares for an estimated $43,903.
• JOHN MILITELLO (See Remarks) has made 0 purchases and 4 sales selling 2,626 shares for an estimated $21,016.
• MARTIN WILSON (General Counsel) has made 0 purchases and 2 sales selling 1,533 shares for an estimated $9,959.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RCKT Hedge Fund Activity

We have seen 147 institutional investors add shares of $RCKT stock to their portfolio, and 86 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC removed 2,613,820 shares (-63.4%) from their portfolio in Q1 2025, for an estimated $17,434,179
• POINT72 ASSET MANAGEMENT, L.P. removed 1,569,823 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $10,470,719
• BOXER CAPITAL MANAGEMENT, LLC removed 1,466,051 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,778,560
• MORGAN STANLEY added 1,457,183 shares (+123.0%) to their portfolio in Q1 2025, for an estimated $9,719,410
• WELLINGTON MANAGEMENT GROUP LLP removed 1,368,686 shares (-9.8%) from their portfolio in Q1 2025, for an estimated $9,129,135
• AVORO CAPITAL ADVISORS LLC removed 1,200,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,004,000
• AVIDITY PARTNERS MANAGEMENT LP removed 1,053,300 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,025,511

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.